When it comes to patient populations, veterans are among the most challenging to treat. Many return from service with debilitating conditions, including PTSD, treatment resistant depression, traumatic brain injury and chronic pain. The costs – both financial and human – of military service are extreme. Recent studies suggest that between 2001 and 2050, the total […]

The post Free Webinar — Psychedelics for Veterans: The Battle for a Better Standard of Care appeared first on Psychedelics Today.

Previous articleatai Life Sciences Company, Perception Neuroscience, Completes Enrollment for Phase 2a Clinical Trial of PCN-101 (R-Ketamine) for Treatment-Resistant Depression
Next articleSilo Pharma to Discuss Mainstream Pharma and Psychedelics at Wonderland Miami Conference